Dublin, Sept. 25, 2018 (GLOBE NEWSWIRE) -- The "Medical Aesthetics Market Product, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6%.
The growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced & user-friendly products, and the increasing demand for aesthetic treatments among men are the key factors driving the growth of this market. On the other hand, market growth is limited to a certain extent by factors such as the clinical risks and complications associated with medical aesthetic procedures and the increasing availability and adoption of alternative beauty and cosmetic products.
On the basis of products, the market is segmented into facial aesthetic products (dermal fillers, botulinum toxin, microdermabrasion, and chemical peels); body contouring devices (nonsurgical fat reduction devices, cellulite reduction devices, and liposuction devices); cosmetic implants [breast implants (silicone implants and saline implants), facial implants, and other cosmetic implants]; hair removal devices (laser hair removal devices and IPL hair removal devices); skin aesthetic devices (laser resurfacing devices, nonsurgical skin tightening devices, micro-needling products, and light therapy devices); tattoo removal devices; thread lift products; physician-dispensed cosmeceuticals and skin lighteners; physician-dispensed eyelash products; and nail treatment laser devices. The facial aesthetic products segment is expected to hold the largest share of the medical aesthetics market in 2018.
The large share of this segment is attributed to the growing patient demand for facial aesthetic treatments, increasing disposable income and spending capabilities, and the rising geriatric population across the globe.
On the basis of end user, the medical aesthetics market is segmented into clinics, hospitals, and medical spas; beauty centers; and home care. The clinics, hospitals, and medical spas segment is estimated to account for the largest share of the global medical aesthetics market in 2018. This end-user segment is also expected to be fastest-growing end-user segment during the forecast period, owing to the increasing number of clinics and medical spas and the high availability of financial and infrastructural resources with hospitals, including technologically advanced devices, trained staff, and skilled professionals to perform aesthetic procedures.
Medical Aesthetics Market
Geographically, this market is divided into North America, Europe, Asia Pacific, and the RoW. North America is expected to account for the largest share of the global medical aesthetics market in 2018, and this trend is expected to continue during the forecast period. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period. Rising consumer knowledge and interest in procedures, strong local economies, aggressive marketing by leading US and European companies in Asia, rising medical tourism, and increasing awareness about aesthetics are some of the key factors driving the growth of the medical aesthetics market in the Asia Pacific.
Product launches, enhancements, and product approvals are the key growth strategies adopted by major players to strengthen their position in the global medical aesthetics market. In addition, strategies such as agreements, partnerships, and collaborations; acquisitions; and expansions were also adopted by several market players to remain competitive in the market.
Allergan, plc (Ireland), Alma Lasers, Ltd. (Israel), Anika Therapeutics (US), Cutera, Inc. (US), Cynosure (US), El.En. S.p.A. (Italy), Fotona d.o.o. (Slovenia), Nestl S.A. (Switzerland), Johnson & Johnson (US), Merz Pharma GmbH & Co. KGaA (Germany), Medytox, Inc. (South Korea), Sientra, Inc. (US), Sinclair Pharma PLC (UK), Syneron Medical, Ltd. (US), and Valeant Pharmaceuticals International, Inc. (US) are some of the key players operating in the global medical aesthetics market.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Medical Aesthetics Market Overview
4.2 Medical Aesthetics Market, By Product
4.3 Regional Analysis: Medical Aesthetics Market, By End Users
4.4 Geographic Snapshot of the Medical Aesthetics Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures
5.2.1.2 Rising Adoption Among Geriatric Individuals
5.2.1.3 Increasing Public Awareness About Cosmetic Procedures
5.2.1.4 Availability of Technologically Advanced and User-Friendly Products
5.2.1.5 Increasing Demand for Aesthetic Treatments Among Men
5.2.2 Restraints
5.2.2.1 Clinical Risks and Complications Associated With Medical Aesthetic Procedures
5.2.2.2 Increasing Availability and Adoption of Alternative Beauty and Cosmetic Products
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Development of Low-Cost Medical Aesthetic Devices
5.2.3.3 Growing Adoption of Home-Use Aesthetic Devices
5.2.3.4 Increasing Disposable Incomes and the Expanding Middle-Class Population
5.2.4 Challenges
5.2.4.1 Social and Ethical Issues Associated With Cosmetic Treatments
6 Medical Aesthetics Market, By Product
6.1 Introduction
6.2 Facial Aesthetic Products
6.2.1 Dermal Fillers
6.2.2 Botulinum Toxin
6.2.3 Microdermabrasion Products
6.2.4 Chemical Peels
6.3 Body Contouring Devices
6.3.1 Nonsurgical Fat Reduction Devices
6.3.2 Cellulite Reduction Devices
6.3.3 Liposuction Devices
6.4 Cosmetic Implants
6.4.1 Breast Implants
6.4.1.1 Silicone Breast Implants
6.4.1.2 Saline Breast Implants
6.4.2 Facial Implants
6.4.3 Other Cosmetic Implants
6.5 Skin Aesthetic Devices
6.5.1 Laser Skin Resurfacing Devices
6.5.2 Nonsurgical Skin Tightening Devices
6.5.3 Micro-Needling Products
6.5.4 Light Therapy Devices
6.6 Physician-Dispensed Eyelash Products
6.7 Physician-Dispensed Cosmeceuticals and Skin Lighteners
6.8 Hair Removal Devices
6.8.1 Laser Hair Removal Devices
6.8.2 IPL Hair Removal Devices
6.9 Tattoo Removal Devices
6.10 Thread Lift Products
6.11 Nail Treatment Laser Devices
7 Medical Aesthetics Market, By End User
7.1 Introduction
7.2 Clinics, Hospitals, and Medical Spas
7.3 Beauty Centers
7.4 Home Care
8 Medical Aesthetics Market, By Region
8.1 Introduction
8.2 North America
8.2.1 Launch and Approvals for Aesthetic Devices
8.2.2 Rapidly Increasing Aging and Obese Population in the US and Canada
8.2.3 Rich Research Pipeline
8.2.4 Lack of Reimbursement and High Cost of Aesthetic Procedures
8.2.5 US
8.2.6 Canada
8.3 Europe
8.3.1 Launch of Novel Aesthetic Products
8.3.2 High Use of Dermal Fillers in Europe
8.3.3 Conferences and Training Programs
8.3.4 Growing Focus of Market Companies on the European Market
8.3.5 Dearth of Pertinent Regulatory Guidelines
8.3.6 Slow Market Growth Due to Reimbursement Issues
8.3.7 Germany
8.3.8 France
8.3.9 UK
8.3.10 Rest of Europe
8.4 Asia Pacific
8.4.1 Growing Middle-Class Population and Purchasing Power in the Region
8.4.2 Growing Preference for Aesthetic Surgery in South Korea
8.4.3 Growing Uses of Neurotoxins
8.4.4 Lack of Reimbursements
8.4.5 Japan
8.4.6 China
8.4.7 India
8.4.8 South Korea
8.4.9 Rest of APAC
8.5 Rest of the World
8.5.1 Rise in Medical Tourism
8.5.2 Increasing Number of Aesthetic Procedures in the Region
8.5.3 Weak Economy and Low Consumer Buying Power in Latam and African Countries
8.5.4 Shortage of Plastic Surgeons in the Middle East and Africa
8.5.5 Latin America
8.5.6 Middle East
8.5.7 Africa
9 Competitive Landscape
9.1 Introduction
9.2 Global Medical Aesthetics Market Share Analysis (2017)
9.2.1 Global Facial Aesthetics Market Share Analysis
9.2.2 Global Medical Aesthetics Market Share Analysis for Energy & Light Based Devices
9.2.3 Global Medical Aesthetics Market Share Analysis for Cosmetic Implants
9.3 Competitive Scenario
9.3.1 Key Product Launches and Approvals (2015-2018)
9.3.2 Agreements, Partnerships, and Collaborations (2015-2018)
9.3.3 Acquisitions (2015-2018)
9.3.4 Expansions (2015-2018)
9.3.5 Investments and Divestments (2015-2018)
10 Company Profiles
10.1 Allergan
10.2 Solta Medical (A Division of Valeant Pharmaceuticals International, Inc.)
10.3 Cynosure (A Wholly Owned Subsidiary of Hologic Inc.)
10.4 Johnson & Johnson
10.5 Merz Aesthetics, Inc. (A Division of Merz Pharma GmbH & Co. KGaA)
10.6 Galderma (A Subsidiary of Nestl)
10.7 Alma Lasers, Ltd. (A Division of Sisram Medical Ltd.)
10.8 Syneron Medical, Ltd. (A Part of APAX Partners)
10.9 El.En. S.P.A.
10.10 Sientra, Inc.
10.11 Anika Therapeutics, Inc.
10.12 Sinclair Pharma PLC
10.13 Medytox, Inc.
10.14 Cutera, Inc.
10.15 Fotona D.O.O.
For more information about this report visit https://www.researchandmarkets.com/research/c8nj4k/global_medical?w=12